ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
166.1
Frequently Asked Questions
What is Market Cap of ProQR Therapeutics N.V?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ProQR Therapeutics N.V market cap is $263.03M.
What is the 52-week high for ProQR Therapeutics N.V?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ProQR Therapeutics N.V 52 week high is $4.62 as of October 10, 2025.
What is the 52-week low for ProQR Therapeutics N.V?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ProQR Therapeutics N.V 52 week low is $1.07 as of October 10, 2025.
What is ProQR Therapeutics N.V stock price today?
ProQR Therapeutics N.V stock price today is $2.46.
What was ProQR Therapeutics N.V stock price yesterday?
ProQR Therapeutics N.V stock price yesterday was $2.50.
What is the PE ratio of ProQR Therapeutics N.V?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. ProQR Therapeutics N.V’s P/E ratio is -5.63.
What is the Price-to-Book ratio of ProQR Therapeutics N.V?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. ProQR Therapeutics N.V P/B ratio is 3.3495.
What is the 50-day moving average of ProQR Therapeutics N.V?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ProQR Therapeutics N.V 50-day moving average is $2.18.
How many employess does ProQR Therapeutics N.V has?
